Homologous or comparable structures are two terms used to describe similar body parts. Both show that evolution has occurred.
<h3>How do the structures in comparative anatomy compare as proof of evolution?</h3>
To comprehend how organisms evolved, scientists compare the DNA, embryos, and anatomical structures of living beings. Homologous structures offer evidence for evolution. These are traits that related species have in common that they inherited from a common ancestor. Analogous structures offer additional proof of evolution.
<h3>How are anatomy and embryology utilized to support evolution?</h3>
The homologous and vestigial structures of different species can be seen, which demonstrates their shared origin. Since the embryonic shapes of different populations are remarkably similar, embryology provides evidence for evolution.
To know more about Homologous visit :-
brainly.com/question/7904813
#SPJ4
Answer:
when we crossed Pp with pp out result will have a phenotype ratio of 2Pp:2Pp or Pp:Pp and genotype will be 50%Pp and 50%Pp.
Explanation:
Nuclear Has The Highest Capacity Factor
That's about 1.5 to 2 times more as natural gas and coal units, and 2.5 to 3.5 times more reliable than wind and solar plants.
The 4 things that both cells have is a plasma membrane, ribosomes, cytoplasm, and DNA!
the 2 basic types of cells are eukaryotic and prokaryotic.
(i had to go digging through my old science notes for this haha)
The correct answer is that mutant cells will exhibit diminished oxygen consumption; decreased glycolysis results in decreased Kreb's cycle and electron transport chain.
The PFK2 enzyme catalyzes the generation of F26BP, this binds with the allosteric site of PFK-1 and increases the affinity of PFK-1 with F6P and also decreases the affinity of allosteric inhibitors citrate and ATP to PFK-1. Thus, PFK-1 will combine with F6P at a greater rate.
This ultimately results in more glycolysis, thus, more ETC and more consumption of O2. If there is no PFK2, then there will be a reduction in glycolysis, TCA, ETC, and consumption of oxygen.
The PFK2 is an enzyme accountable for monitoring the rates of gluconeogenesis and glycolysis in the human body. In the absence of glycolysis, there will be a reduction in TCA, ETC, and consumption of O2.